The Patent Finder
US

Chimeric Factor VIII Polypeptides and Uses Thereof

US 11,370,827 In force
OverviewFamilyAssignmentsSources & methods

Also listed on Biogen Idec Ma Inc., an earlier holder on the record. The recorded assignments below show how it moved.

Term ends Jan 4, 2034 · High confidence

Filed Jul 11, 2014 as application 14/371,948 · Granted Jun 28, 2022
Base term plus 1008 days of patent term adjustment (USPTO delay) · capped by a resolved terminal disclaimer
Today
20 years from filing
2013 2034
Clock starts
Jan 12, 2013
Term ends
Jan 4, 2034
Granted
Jun 28, 2022
base term patent term adjustment fee events Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
1,008
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 10,138,291, US 11,192,936.
1 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
4
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term runs 1008 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. 1 of 2 maintenance fees is paid so far. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Jan 12, 2013, when application PCT/US2013/021330, the earliest non-provisional in its chain, was filed (this one was filed Jul 11, 2014)Jan 12, 2033High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustment+1008 days, USPTO patent term adjustment recordOct 17, 2035High confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 10,138,291, US 11,192,936)capped to Jan 4, 2034High confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events1 of 2 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderJan 4, 2034High confidence

This family

Application PCT/US2013/021330PCT application
no patent term
no patent term
US 11,370,827this patent
Jan 2034
Jan 2034
Application 17/826,932Pending
not computed
not computed
Application 19/397,119Pending
not computed
not computed
The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
May 4, 2015
Reel 35571, frame 926
Biogen Idec Ma Inc.Biogen Ma Inc.Change of Name
Feb 26, 2017
Reel 41816, frame 1
Biogen Ma Inc.Bioverativ Therapeutics Inc.Assignment of Assignor's Interest
Mar 1, 2017
Reel 41414, frame 927
Chhabra, Ekta Seth; Liu, Tongyao; Peters, Robert T.; Jiang, HaiyanBiogen Idec Ma Inc.Assignment of Assignor's Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited